Colgate-Palmolive Co. (CL)
Why Colgate-Palmolive (CL) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Colgate Gains 21.3% YTD: What Makes the Stock Apt to Retain?
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Colgate-Palmolive Company (CL) Morgan Stanley Global Consumer & Retail Conference - (Transcript)
Colgate-Palmolive Company (NYSE:CL ) Morgan Stanley Global Consumer & Retail Conference Call December 3, 2024 11:45 AM ET Company Participants Stanley Sutula III - Chief Financial Officer Panagiotis Tsourapas - Group President, Europe and Developing Markets Conference Call Participants Dara Mohsenian - Morgan Stanley Dara Mohsenian Good morning, everyone. I'm Dara Mohsenian, Morgan Stanley's Household Products and Beverage Analyst.
CL's Pricing & Productivity Efforts Bode Well: Apt to Hold the Stock?
Colgate benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
3 Reasons Why Growth Investors Shouldn't Overlook Colgate-Palmolive (CL)
Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Consumer Staples Stocks Lagging ColgatePalmolive (CL) This Year?
Here is how Colgate-Palmolive (CL) and Lancaster Colony (LANC) have performed compared to their sector so far this year.
Cramer's Stop Trading: Colgate-Palmolive
CNBC's Jim Cramer explains why he is keeping an eye on shares of Colgate-Palmolive.
Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Colgate-Palmolive Company's Q3 earnings showed mixed results, with revenue and EPS beating estimates but North America and Latin America sales declining, leading to a 3% stock drop. The company's improved gross margins and increased advertising spend are positive signs, but the market remains concerned about regional sales declines. The Pet Nutrition segment shows strong growth potential, driven by the pet humanization trend, and could be a key revenue catalyst.
Colgate Beats Q3 Earnings & Sales Estimates, Raises 2024 View
CL's Q3 results reflect continued gains from volume and pricing, which led to organic sales growth in five of six divisions. Improved margins aid EPS growth.
Colgate-Palmolive (CL) Q3 2024 Earnings Call Transcript
Colgate-Palmolive Company (NYSE:CL ) Q3 2024 Earnings Conference Call October 25, 2024 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer & SVP, M&A Noel Wallace - President & CEO Stan Sutula - CFP Conference Call Participants Dara Mohsenian - Morgan Stanley Filippo Falorni - Citi Robert Moskow - TD Cowen Bonnie Herzog - Goldman Sachs Kevin Grundy - BNP Lauren Lieberman - Barclays Kaumil Gajrawala - Jefferies Chris Carey - Wells Fargo Olivia Tong - Raymond James Robert Ottenstein - Evercore ISI Andrea Teixeira - JP Morgan Bryan Spillane - Bank of America Korinne Wolfmeyer - Piper Sandler Steve Powers - Deutsche Bank Mark Astrachan - Stifel Edward Lewis - Redburn Atlantic Operator Good morning. Welcome to today's Colgate-Palmolive 2024 Third Quarter Earnings Conference Call.
Compared to Estimates, Colgate-Palmolive (CL) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Colgate-Palmolive lifts lower end of full-year sales guidance after beating Q3 estimates
Colgate-Palmolive Co (NYSE:CL) has raised the lower end of its 2024 guidance following a strong third quarter for the diversified consumer goods company. The toothpaste maker's Q3 revenue of $5.03 billion beat estimates of $5.01 billion and earnings per share (EPS) of $0.91 was ahead of the consensus of $0.88.
